PATENT CLAIM ANALYSIS

Application Number: 15993051
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "264110"]

Abstract:
The invention relates to substituted tetrahydro-pyrido-pyrimidine derivatives of the formula (I), wherein Y, R1, R2 and m are as defined in the description. Such compounds are suitable for the treatment of a disorder or disease which is mediated by the activity of the PI3K enzymes.

Claim (Index 15):
A pharmaceutical combination comprising a therapeutically effective amount of a salt form according to  claim 1 , and one or more therapeutically active agents.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 93.0
- Lexical Diversity: 1.2381
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13175050', '14151796', '13721805', '14976998', '15509569']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7615072598443158
- 35 USC 102 Novelty (BERT): 0.5695110261469608
- Combined Prediction Score: 0.7423076364745803
- Mean Citation Score: 370.789852
- Max Citation Score: 453.04373
- Similarity Product: 371.747744106403

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test